Serum concentration of the pyridinium cross-links, pyridinoline (Pyr) and deoxypyridinoline (Dpyr), which are markers of bone resorption, was measured by high-perfomance liquid chromatography in 56 patients on maintenance hemodialysis. The following analyses were conducted: 1) correla-tion with known markers of bone metabolism, 2 ) correlation with findings on bone changes on plain X-ray film, 3 ) elimination rates by hemodialysis, and 4 ) increment per day in pyridinoline after hemodialysis ( Δ Pyr/ day) . There was a very close correlation found between serum Pyr and Dpyr (r =0.861). Both serum Pyr and Dpyr showed correlations with known markers of bone metabolism: C-PTH (r =0.806 and r =0.747, respectively), M-PTH (r =0.766 and r =0.749), osteocalcin (r =0.717 and r =0.693), Alp-3 (r =0.523 and r =0.441) and tartrateresistant acid phosphatase (r =0.549 and r = 0.548). In addition, a correlation between the duration of hemodialysis and serum Pyr and Dpyr was observed (r =0.426 and r =0.318, respectively). When comparing the mean values of serum Pyr or Dpyr in three groups of patients divided according to bone changes seen on plain X-ray film, there were statistically significant differences between the group without bone changes and the remaining two groups with some bone changes (p<0.05) . A mean of 45.3 % of serum Pyr was removed by hemodialysis. The serum Pyr level returned alomst to the original concentration by the following hemodialysis. ΔPyr/ day showed a close correlation with C-PTH (r = 0.656). There was a very close correlation between serum Pyr and ΔPyr/ day (r = 0.830). These results indicate that serum Pyr and Dpyr are useful parameters of renal osteodystrophy. However, samplings should be made under uniform conditions.
抄録全体を表示